These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine. Tiraby M; Cazaux C; Baron M; Drocourt D; Reynes JP; Tiraby G FEMS Microbiol Lett; 1998 Oct; 167(1):41-9. PubMed ID: 9785450 [TBL] [Abstract][Full Text] [Related]
6. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Mullen CA; Kilstrup M; Blaese RM Proc Natl Acad Sci U S A; 1992 Jan; 89(1):33-7. PubMed ID: 1729703 [TBL] [Abstract][Full Text] [Related]
7. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine. Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204 [TBL] [Abstract][Full Text] [Related]
8. Selectable marker-free transgenic plants without sexual crossing: transient expression of cre recombinase and use of a conditional lethal dominant gene. Gleave AP; Mitra DS; Mudge SR; Morris BA Plant Mol Biol; 1999 May; 40(2):223-35. PubMed ID: 10412902 [TBL] [Abstract][Full Text] [Related]
9. A bacterial gene codA encoding cytosine deaminase is an effective conditional negative selectable marker in Glycine max. Shao M; Michno JM; Hotton SK; Blechl A; Thomson J Plant Cell Rep; 2015 Oct; 34(10):1707-16. PubMed ID: 26082433 [TBL] [Abstract][Full Text] [Related]
10. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas. Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532 [TBL] [Abstract][Full Text] [Related]
11. Construction and testing of gene therapy retroviral vector expressing bacterial cytosine deaminase gene. Hlavatý J; Hlubinová K; Altaner C Neoplasma; 1999; 46(5):267-76. PubMed ID: 10665841 [TBL] [Abstract][Full Text] [Related]
12. Human nerve growth factor receptor and cytosine deaminase fusion genes. Lewis VA; Basso L; Blake N; Salo J; Lund TC; McIvor RS; Orchard PJ Hum Gene Ther; 2003 Jul; 14(10):1009-16. PubMed ID: 12869218 [TBL] [Abstract][Full Text] [Related]
13. A negative selection scheme based on the expression of cytosine deaminase in plastids. Serino G; Maliga P Plant J; 1997 Sep; 12(3):697-701. PubMed ID: 9351253 [TBL] [Abstract][Full Text] [Related]
14. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. Pierrefite-Carle V; Baqué P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026 [TBL] [Abstract][Full Text] [Related]
15. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Austin EA; Huber BE Mol Pharmacol; 1993 Mar; 43(3):380-7. PubMed ID: 8450832 [TBL] [Abstract][Full Text] [Related]
16. Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer. Rowley S; Lindauer M; Gebert JF; Haberkorn U; Oberdorfer F; Moebius U; Herfarth C; Schackert HK J Surg Oncol; 1996 Jan; 61(1):42-8. PubMed ID: 8544459 [TBL] [Abstract][Full Text] [Related]
17. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor. Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281 [TBL] [Abstract][Full Text] [Related]
18. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration. Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940 [TBL] [Abstract][Full Text] [Related]
19. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418 [TBL] [Abstract][Full Text] [Related]
20. Cytosine deaminase gene as a positive selection marker. Wei K; Huber BE J Biol Chem; 1996 Feb; 271(7):3812-6. PubMed ID: 8631998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]